Divergent memory responses driven by adenoviral vectors are impacted by epitope competition.
Journal article
Colston JM. et al, (2019), Eur J Immunol, 49, 1356 - 1363
Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.
Journal article
Atcheson E. et al, (2019), Hepatology
First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults.
Journal article
Cicconi P. et al, (2019), Clin Infect Dis
Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
Journal article
Green CA. et al, (2019), J Infect, 78, 382 - 392
Single-cell transcriptome analysis of CD8 + T-cell memory inflation.
Journal article
Highton AJ. et al, (2019), Wellcome Open Res, 4
Memory inflation following adenoviral vaccination depends on IL-21.
Journal article
Gordon CL. et al, (2018), Vaccine, 36, 7011 - 7016
Induction and Maintenance of CX3CR1-Intermediate Peripheral Memory CD8+ T Cells by Persistent Viruses and Vaccines.
Journal article
Gordon CL. et al, (2018), Cell Rep, 23, 768 - 782
The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes.
Journal article
von Delft A. et al, (2018), Vaccine, 36, 313 - 321
Adenoviral vaccine induction of CD8+ T cell memory inflation: Impact of co-infection and infection order.
Journal article
Lee LN. et al, (2017), PLoS Pathog, 13
Helicobacter hepaticus infection in BALB/c mice abolishes subunit-vaccine-induced protection against M. tuberculosis.
Journal article
Arnold IC. et al, (2015), Vaccine, 33, 1808 - 1814
Helicobacter hepaticus infection in BALB/c mice abolishes subunit-vaccine-induced protection against M. tuberculosis
Journal article
Arnold IC. et al, (2015), Vaccine, 33, 1808 - 1814
A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis.
Journal article
Beverley PCL. et al, (2014), J Immunol, 193, 2306 - 2316
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
Journal article
O'Hara GA. et al, (2012), J Infect Dis, 205, 772 - 781
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine.
Journal article
Porter DW. et al, (2011), Vaccine, 29, 7514 - 7522
Correction: Multiple functions of human T cells generated by experimental malaria challenge
Journal article
Todryk SM. et al, (2011), European Journal of Immunology, 41
Multiple functions of human T cells generated by experimental malaria challenge.
Journal article
Todryk SM. et al, (2009), Eur J Immunol, 39, 3042 - 3051
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria.
Journal article
Schmidt NW. et al, (2008), Proc Natl Acad Sci U S A, 105, 14017 - 14022
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.
Journal article
Thompson FM. et al, (2008), PLoS One, 3
Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.
Journal article
Hutchings CL. et al, (2007), Infect Immun, 75, 5819 - 5826
New insights into the altered adhesive and mechanical properties of red blood cells parasitized by Babesia bovis.
Journal article
Hutchings CL. et al, (2007), Mol Microbiol, 65, 1092 - 1105